Cytek Biosciences (CTKB) News Today $4.14 -0.03 (-0.72%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.14 +0.00 (+0.12%) As of 08/29/2025 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTKB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Topline Capital Management LLC Increases Stock Position in Cytek Biosciences, Inc. $CTKBAugust 30 at 8:04 AM | marketbeat.comVanguard Group Inc. Sells 2,094,835 Shares of Cytek Biosciences, Inc. $CTKBAugust 29 at 3:14 AM | marketbeat.comCytek Biosciences management to meet virtually with Piper SandlerAugust 25, 2025 | msn.comCytek Biosciences, Inc. $CTKB Shares Purchased by Public Sector Pension Investment BoardAugust 24, 2025 | marketbeat.comCytek Biosciences Earnings Call Reveals Mixed OutlookAugust 23, 2025 | theglobeandmail.comConnor Clark & Lunn Investment Management Ltd. Reduces Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)August 18, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Cytek Biosciences (CTKB), Natera (NTRA) and Warby Parker (WRBY)August 12, 2025 | theglobeandmail.comCytek Biosciences to Participate in Upcoming Investor ConferencesAugust 12, 2025 | globenewswire.comCytek Biosciences price target lowered to $4 from $7 at Morgan StanleyAugust 12, 2025 | msn.comCytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comCytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comCytek Biosciences: Q2 2025 Financial Performance OverviewAugust 7, 2025 | tipranks.comCytek Biosciences Inc (CTKB) Q2 2025 Earnings Report Preview: What To Look ForAugust 6, 2025 | finance.yahoo.comCytek Biosciences Reports Second Quarter 2025 Financial ResultsAugust 6, 2025 | globenewswire.comXTX Topco Ltd Purchases 149,373 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)August 5, 2025 | marketbeat.comCytek Biosciences And 2 Other Penny Stocks Worth WatchingJuly 30, 2025 | finance.yahoo.comCytek Biosciences (CTKB) Projected to Post Earnings on WednesdayJuly 30, 2025 | marketbeat.comRoyce & Associates LP Purchases 95,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)July 29, 2025 | marketbeat.comCytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Teachers Retirement System of The State of KentuckyJuly 26, 2025 | marketbeat.comCytek Biosciences, Inc. (CTKB): A Bull Case TheoryJuly 24, 2025 | insidermonkey.comCenterBook Partners LP Makes New $3.39 Million Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB)July 15, 2025 | marketbeat.comAcuitas Investments LLC Buys New Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)July 2, 2025 | marketbeat.comCytek Biosciences (NASDAQ:CTKB) Trading Up 2.4% - Still a Buy?July 2, 2025 | marketbeat.comCytek Biosciences shareholders elect directors and approve auditor at annual meeting - Investing.comJune 26, 2025 | investing.comCytek Biosciences (CTKB) Faced Challenges from NIH Funding ReductionsJune 11, 2025 | msn.comInsider Buying: Cytek Biosciences, Inc. (NASDAQ:CTKB) CFO Buys 35,000 Shares of StockJune 4, 2025 | marketbeat.comCytek Biosciences, Inc. (NASDAQ:CTKB) CFO William D. Mccombe Buys 35,000 SharesJune 4, 2025 | marketbeat.comCytek Biosciences, Inc. (NASDAQ:CTKB) CFO William D. Mccombe Purchases 35,000 SharesJune 4, 2025 | insidertrades.comWellington Management Group LLP Cuts Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)June 3, 2025 | marketbeat.comBank of America Corp DE Boosts Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB)June 3, 2025 | marketbeat.comAmeriprise Financial Inc. Has $1.62 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB)June 1, 2025 | marketbeat.comCytek Biosciences Launches Cytek Aurora™ Evo System Enhancing Full Spectrum Flow Cytometry CapabilitiesMay 31, 2025 | nasdaq.comCytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Millennium Management LLCMay 30, 2025 | marketbeat.comCytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo SystemMay 30, 2025 | msn.comBeyond The Numbers: 4 Analysts Discuss Cytek Biosciences StockMay 29, 2025 | benzinga.comCytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow CytometerMay 29, 2025 | globenewswire.comMorgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock PriceMay 29, 2025 | marketbeat.comCytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare ConferenceMay 28, 2025 | globenewswire.comPoint72 Asset Management L.P. Makes New Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 23, 2025 | marketbeat.comBNP Paribas Financial Markets Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 22, 2025 | marketbeat.comCytek Biosciences, Inc. (NASDAQ:CTKB) Stake Raised by Northern Trust CorpMay 21, 2025 | marketbeat.comCubist Systematic Strategies LLC Purchases Shares of 116,624 Cytek Biosciences, Inc. (NASDAQ:CTKB)May 17, 2025 | marketbeat.comCytek Biosciences (NASDAQ:CTKB) Price Target Lowered to $3.00 at The Goldman Sachs GroupMay 14, 2025 | marketbeat.comCytek Biosciences (NASDAQ:CTKB) Releases Earnings Results, Misses Expectations By $0.05 EPSMay 12, 2025 | marketbeat.comDimensional Fund Advisors LP Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 12, 2025 | marketbeat.comCytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comCytek Biosciences (NASDAQ:CTKB) Stock Rating Lowered by TD CowenMay 11, 2025 | marketbeat.comCytek Biosciences: Earnings Call Reveals Mixed FortunesMay 9, 2025 | tipranks.comRaymond James Financial Inc. Invests $765,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 9, 2025 | marketbeat.comCytek Biosciences Reports Q1 2025 Financial ResultsMay 8, 2025 | tipranks.com Get Cytek Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTKB Media Mentions By Week CTKB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTKB News Sentiment▼1.361.11▲Average Medical News Sentiment CTKB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTKB Articles This Week▼43▲CTKB Articles Average Week Get the Latest News and Ratings for CTKB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cytek Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 10x Genomics News Transcat News Eyepoint Pharmaceuticals News Allient News Aehr Test Systems News Standard BioTools News Senseonics News Frequency Electronics News 908 Devices News Quantum-Si News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTKB) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytek Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTKB Stock Alerts